Please provide your email address to receive an email when new articles are posted on . CHICAGO — Pellucid marginal corneal degeneration is a rare disease, but early diagnosis is necessary to ensure ...

The US Food and Drug Administration (FDA) has cleared GenEditBio Limited’s Investigational New Drug (IND) application to ...

Cyclosporine 0.09% significantly improves CFS scores and tear production in patients with uncontrolled dry eye disease, including those with MGD. Scleral lenses offer a non-surgical intervention for ...

Please provide your email address to receive an email when new articles are posted on . Pellucid marginal degeneration is a corneal ectatic disorder primarily involving the peripheral inferior ...

Scientists at USC are launching a new trial to test a tiny stem cell implant that could restore vision in people with ...

GenEditBio Limited ("GenEditBio"), a clinical-stage biotechnology startup focusing on genome-editing therapeutic solutions, today announced that the U.S. Food and Drug Administration (FDA) has cleared ...

Medication is not always necessary or the best choice for treating a vision problem, and sometimes, medication isn't an ...

Medically reviewed by Christine L. Larsen, MD Key Takeaways Macular degeneration is a common eye disease, affecting more than 19 million people in the United States alone.The condition can reduce a ...